Fortune USA 201904

74

FORTUNE.COM

WRITING RECIPES

Pharnext CEO
Daniel Cohen with
the molecular
diagrams for
baclofen and
naltrexone—two
of the drugs that
his company has
combined into a
novel therapy.

BA

CL

OF

EN

:^ M

OL

EK

UU

L_

BE

—S

HU

TT

ER

ST

OC

K;^

NA

LT

RE

XO

NE

:^ G

RE

G^ W

ILL

IAM

S—

SC

IEN

CE

SO

UR

CE